Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.42% |
| 3 | Communication Services | 1.04% |
| 4 | Healthcare | 0.74% |
| 5 | Financials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Procter & Gamble
PG
$336B
| $496M | 0.19% |
5,447,700
-182,700
| -3% | -$16.6M |
|
77
CALL
Bristol-Myers Squibb
BMY
$137B
| $487M | 0.19% |
7,646,600
+908,400
| +13% | +$53M |
|
|
78
CALL
Gilead Sciences
GILD
$181B
| $482M | 0.19% |
5,951,900
+1,889,400
| +47% | +$144M |
|
79
Micron Technology
MU
$1.09T
| $477M | 0.18% |
12,118,181
-1,490,433
| -11% | -$47.1M |
|
80
PUT
Baidu
BIDU
$31.6B
| $472M | 0.18% |
1,906,900
-99,800
| -5% | -$21.8M |
|
|
PX
81
CALL
DELISTED
Praxair Inc
PX
| $472M | 0.18% |
3,378,800
+62,800
| +2% | +$8.37M |
|
|
82
CALL
Micron Technology
MU
$1.09T
| $471M | 0.18% |
11,972,200
+3,254,700
| +37% | +$103M |
|
83
PUT
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $467M | 0.18% |
18,042,600
-4,149,500
| -19% | -$104M |
|
84
CALL
Goldman Sachs
GS
$303B
| $459M | 0.18% |
1,935,300
+741,700
| +62% | +$167M |
|
85
PUT
iShares China Large-Cap ETF
FXI
$4.28B
| $457M | 0.18% |
10,387,100
+2,974,700
| +40% | +$127M |
|
86
CALL
iShares MSCI EAFE ETF
EFA
$80B
| $450M | 0.17% |
6,577,000
-7,261,800
| -52% | -$485M |
|
87
Meta Platforms (Facebook)
META
$1.4T
| $448M | 0.17% |
2,623,032
+660,998
| +34% | +$110M |
|
88
PUT
McDonald's
MCD
$192B
| $447M | 0.17% |
2,852,800
+734,200
| +35% | +$115M |
|
|
89
Gilead Sciences
GILD
$181B
| $441M | 0.17% |
5,442,665
-4,690,264
| -46% | -$359M |
|
90
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $435M | 0.17% |
972,700
-96,800
| -9% | -$46.1M |
|
91
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $435M | 0.17% |
2,371,700
-151,900
| -6% | -$26.8M |
|
92
CALL
Costco
COST
$420B
| $430M | 0.17% |
2,618,100
+1,365,800
| +109% | +$215M |
|
93
CALL
Chipotle Mexican Grill
CMG
$46.7B
| $422M | 0.16% |
68,465,000
+1,255,000
| +2% | +$8.45M |
|
94
CALL
Biogen
BIIB
$32B
| $421M | 0.16% |
1,343,800
-322,800
| -19% | -$95.6M |
|
95
CALL
Verizon
VZ
$205B
| $420M | 0.16% |
8,475,200
+2,541,600
| +43% | +$120M |
|
|
96
PUT
Biogen
BIIB
$32B
| $418M | 0.16% |
1,336,100
-214,600
| -14% | -$63.5M |
|
97
PUT
GE Aerospace
GE
$361B
| $406M | 0.16% |
3,503,270
-285,574
| -8% | -$34.5M |
|
98
PUT
United States Oil Fund
USO
$2.24B
| $401M | 0.15% |
4,805,513
-1,516,637
| -24% | -$119M |
|
99
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$268M
| $400M | 0.15% |
1,553
+1,131
| +268% | +$435M |
|
100
CALL
Walt Disney
DIS
$186B
| $395M | 0.15% |
4,008,300
-3,937,700
| -50% | -$405M |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $19.7B of net new capital in Q3 2017, opening 1,312 new positions and adding to 3,605 existing holdings. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $474M trimmed.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.